Long-Term Efficacy and Safety of Immunomodulatory Therapy for Atherosclerosis Lakshmi Narasimha ThotaThiruvelselvan PonnusamyLakshmi Mundkur ORIGINAL ARTICLE 22 July 2019 Pages: 385 - 398
Resolvin D1 Attenuates Myocardial Infarction in a Rodent Model with the Participation of the HMGB1 Pathway Rui LiuZhenkun LiQiang Wang ORIGINAL ARTICLE 06 July 2019 Pages: 399 - 406
Effects of PDE-5 Inhibition on the Cardiopulmonary System After 2 or 4 Weeks of Chronic Hypoxia Coline NydeggerAntonio F. CornoGiuseppina Milano ORIGINAL ARTICLE Open access 01 July 2019 Pages: 407 - 414
Obesity-Related Genetic Determinants of Heart Failure Prognosis R. M. AgraM. Gago-DominguezJ. R. Gonzalez-Juanatey ORIGINAL ARTICLE 17 June 2019 Pages: 415 - 424
Safe and Efficacious Use of 1-Month Triple Therapy in Patients with Atrial Fibrillation and High Bleeding Risk Undergoing PCI Antonia SambolaHéctor BuenoDavid García-Dorado ORIGINAL ARTICLE 22 July 2019 Pages: 425 - 433
Effect of Tofogliflozin on Systolic and Diastolic Cardiac Function in Type 2 Diabetic Patients Munemitsu OtagakiKoichiro MatsumuraIchiro Shiojima ORIGINAL ARTICLE 18 July 2019 Pages: 435 - 442
Attainment of Guideline-Directed Medical Treatment in Stable Ischemic Heart Disease Patients With and Without Chronic Kidney Disease Efstratios KoutroumpakisElvira O. GosmanovaRadmila Lyubarova ORIGINAL ARTICLE 23 May 2019 Pages: 443 - 451
Effect of a Therapeutic Strategy Guided by Lung Ultrasound on 6-Month Outcomes in Patients with Heart Failure: Randomized, Multicenter Trial (EPICC Study) Manuel Méndez BailónJose María Cepeda RodrigoSpanish Study Groups of Heart Failure and Clinical Echography of the Spanish National Society of Internal Medicine ORIGINAL ARTICLE 22 July 2019 Pages: 453 - 459
Pirfenidone in Heart Failure with Preserved Ejection Fraction—Rationale and Design of the PIROUETTE Trial Gavin A. LewisErik B. SchelbertChristopher A. Miller ORIGINAL ARTICLE Open access 08 May 2019 Pages: 461 - 470
Efficacy of Antiplatelet Agent Usage for Primary and Secondary Prevention in Dialysis Patients: a Nationwide Data Survey and Propensity Analysis Zheng-Wei ChenCho-Kai WuLian-Yu Lin ORIGINAL ARTICLE 08 May 2019 Pages: 471 - 479
Oral Anticoagulation for Atrial Fibrillation Thromboembolism Prophylaxis in the Chronic Kidney Disease Population: the State of the Art in 2019 Lane ZhangDavid A. SteckmanMandeep S. Sidhu ORIGINAL ARTICLE 04 June 2019 Pages: 481 - 488
The Role of Non-coding RNAs in Ischemic Myocardial Reperfusion Injury Vince SiebertJoseph AllencherrilYochai Birnbaum ORIGINAL ARTICLE 22 July 2019 Pages: 489 - 498
After the AUGUSTUS Trial, Should Apixaban Be the Only Direct Oral Anticoagulant to Be Used in Triple Therapy in Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention? Andrea RubboliMatteo Lisi LETTER TO THE EDITOR 10 May 2019 Pages: 499 - 500